MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617075181 A) filed by Merck Sharp & Dohme LLC on June 17, 2026, for Agonists Of Trem2 Activity.
Inventors include Achab, Abdelghani; Anantpur, Manasi; Boyko, Yaroslav; Burgess, Samantha A.; Chen, Joanna L.; Dimauro, Erin F.; Edelstein, Emma Kate; Gulati, Anmol; Henderson, Timothy J. Number; Liu, Ping; Lux, Michaelyn C.; Rickard, Meredith M.; Simov, Vladimir; Vara, Brandon A.; and Zheng, Xiao Mei.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: The present disclosure is directed to compounds of Formula I and their use as TREM2 agonists for treatment and prevention of a neurodegenerative disorder associated with a loss of function of human TREM2. The disclosed TREM2 agonists may be useful for the treatment of Alzheimer's Disease and associated neurological conditions.
Disclaimer: Curated by HT Syndication.
